CeraVe Diabetes Mellitus - Trial NCT04724967
Access comprehensive clinical trial information for NCT04724967 through Pure Global AI's free database. This Phase 4 trial is sponsored by University of Miami and is currently Completed. The study focuses on Diabetes Complications. Target enrollment is 16 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University of Miami
Timeline & Enrollment
Phase 4
Mar 12, 2021
Aug 10, 2021
Primary Outcome
Percentage of participants reporting adverse events (AE),Frequency of participants reporting adverse events (AE),Physician-assessed Global Aesthetic Improvement Scale (GAIS)
Summary
The purpose of this study is to evaluate the safety and efficacy of the CeraVe Diabetic Skin
 Line for the improvement of skin condition in patients with diabetes mellitus.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT04724967
Non-Device Trial